ITI's Michael Connolly, Manager of Process Development, presents a poster titled, "Functional evaluation of isoforms present in pDNA vaccines" at Aldevron's corporate offices located in Fargo, North Dakota A detailed abstract ...
The AACR Annual Meeting program covers the latest discoveries across the spectrum of cancer research—from population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy—and ...
The BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies. Because our mission is to ...
Reporting on Rapid Advancements of Clinical, Scientific and Business Developments in IO Immuno-Oncology 360° addresses business aspects, clinical advancements and scientific data for cancer immunotherapy that helps advance technology platforms ...
2019 J.P. Morgan Health Care Investor Conference January 6 - 10, 2019 The Annual J.P. Morgan Healthcare Conference will take place January 6-10, 2019. This event continues to be one of ...
The ASCO-SITC Clinical Immuno-Oncology Symposium is a three-day meeting focused on clinical and translational research in immuno-oncology and the implications for clinical care. https://immunosym.org/
Immunomic Therapeutics Senior Director of Corporate Development to Present at Precision Lung Cancer World R&D Summit Discussion of lysosomal targeting technology as applied in cancer immunotherapy October 26, 2018 07:30 ...
Immunomic Therapeutics CEO to Present at NYC Oncology Investor Conference To Discuss UNITE Technology Application in Oncology October 23, 2018 07:00 AM Eastern Daylight Time NEW YORK--(BUSINESS WIRE)--Immunomic Therapeutics, ...
Panel to Highlight Advanced Therapeutics for Oncology October 03, 2018 12:00 AM Eastern Daylight Time BASEL, Switzerland--(BUSINESS WIRE)--Tomorrow, William Hearl, Ph.D., Chief Executive Officer (CEO) of Immunomic Therapeutics, Inc., will ...
Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company presented at the 2018 BIO Investor Forum held in San Francisco, CA on October 17-18. William Hearl, Ph.D., Immunomic’s Founder ...
Immunomic Therapeutics, Inc. Founder and CEO Bill Hearl Joins Rich Bendis for BioTalk Click to hear the interview: Bill Hearl Q&A Dr. Bill Hearl is the Founder and Chief Executive Officer ...
Our very own Dr. Heiland has been featured on BioBuzz. Click below to read the full Q&A Interview, as Dr. Heiland discusses our technology platform name change to UNITE and ...